Drug:
Reaction: ECZEMA
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940243 |
US |
72 | 1 |
Sleep disorder due to a general medical condition, Eczema, Pruritus, Emotional disorder, Arthralgia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2 | 26940337 |
US |
58 | |
Infection, Abscess, Eczema, Product dose omission issue, |
||||
| 3 | 26940454 |
US |
5 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 4 | 26940478 |
US |
36 | 2 |
Eczema, Rash, |
||||
DUPILUMAB, |
||||
| 5 | 26940763 |
US |
2 | |
Hernia repair, Scar, Fear of injection, Allergy to chemicals, Otorrhoea, Visual impairment, Nasal congestion, Sinusitis, Hernia, Dyspepsia, Eczema, Dyspnoea, Dizziness, Blood pressure increased, Nausea, Palpitations, Blood calcium increased, Headache, Arthralgia, Incorrect dose administered, Product distribution issue, Intentional dose omission, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, CALCIUM, |
||||
| 6 | 26940821 |
US |
22 | 2 |
Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 7 | 26940826 |
US |
2 | |
Eczema, Therapeutic response decreased, |
||||
DUPILUMAB, LORATADINE, LORATADINE TABLET, |
||||
| 8 | 26941284 |
US |
53 | 2 |
Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 9 | 26941312 |
US |
12 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 10 | 26941314 |
US |
43 | 2 |
Eczema, Pruritus, Sleep disorder, Rash, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, RUXOLITINIB, |
||||
| 11 | 26941319 |
US |
22 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 12 | 26941328 |
US |
1 | |
Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 13 | 26941872 |
CA |
53 | |
Cardiac murmur, Colitis ulcerative, Impaired quality of life, Pneumonia, Condition aggravated, Frequent bowel movements, Adverse drug reaction, Migraine, Blood cholesterol increased, Bronchiectasis, Hypopnoea, Pain in extremity, Rhinitis, Lymphocyte count decreased, Eczema, Parosmia, Steroid dependence, Abdominal discomfort, Gingival pain, Pulmonary embolism, Catarrh, COVID-19, Vertigo, Impaired work ability, Arthritis, Swollen tongue, Tubulointerstitial nephritis, Palpitations, Dysgeusia, Cerebrovascular accident, Nightmare, Pain, Deep vein thrombosis, Stress, Neutrophil count increased, Monocyte count decreased, C-reactive protein increased, Haemoglobin decreased, Platelet count increased, Haematocrit decreased, Haematochezia, Uterine leiomyoma, Gamma-glutamyltransferase increased, Red cell distribution width increased, Mean cell haemoglobin concentration decreased, Red blood cell count decreased, Mean platelet volume decreased, Depression, Systemic lupus erythematosus, Abdominal lymphadenopathy, Confusional state, Headache, Tinnitus, Somnolence, Rash, Hypersensitivity, Rectal haemorrhage, Pyrexia, Weight decreased, Burns second degree, Alcohol poisoning, Inappropriate schedule of product administration, Product use in unapproved indication, Off label use, Drug ineffective, Accidental overdose, Fatigue, |
||||
ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, OXYCODONE, OXYCODONE, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, PREDNISONE, PREDNISONE, PREDNISONE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ERGOCALCIFEROL, MESALAMINE, CALCIUM CARBONATE, ANTACID, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, EPINEPHRINE HYDROCHLORIDE, CANDESARTAN CILEXETIL, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, INFLIXIMAB-DYYB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, VEDOLIZUMAB, VEDOLIZUMAB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, MESALAMINE, MESALAMINE, RAMIPRIL, PRAVASTATIN SODIUM, MESALAMINE, MESALAMINE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, INFLIXIMAB-DYYB, ERGOCALCIFEROL, FESOTERODINE FUMARATE, |
||||
| 14 | 26942118 |
US |
2 | |
Eczema, Erythema, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 15 | 26942133 |
US |
57 | 2 |
Dermatitis atopic, Eczema, |
||||
DUPILUMAB, |
||||
| 16 | 26942440 |
US |
65 | 2 |
Cataract, Eczema, |
||||
DUPILUMAB, |
||||
| 17 | 26942481 |
US |
27 | 2 |
Eczema, Dry skin, Eyelid skin dryness, |
||||
DUPILUMAB, |
||||
| 18 | 26942827 |
US |
4 | 2 |
Eczema, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 19 | 26942880 |
US |
39 | 1 |
Eczema, Rash erythematous, Dry skin, Rash pruritic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 20 | 26944913 |
EU |
55 | 1 |
Eczema, Suspected off label use, |
||||
RITUXIMAB, |
||||
| 21 | 26945027 |
US |
74 | 2 |
Chills, Pyrexia, Eczema, Headache, Injection site pain, Rash, Injection site reaction, |
||||
ABALOPARATIDE, ABALOPARATIDE, CALCIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, POLYETHYLENE GLYCOL 3350, FAMOTIDINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 22 | 26945078 |
US |
2 | |
Eczema, |
||||
ABALOPARATIDE, |
||||
| 23 | 26945471 |
US |
23 | 2 |
Eczema, Rash erythematous, Rash, Rash pruritic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 24 | 26945851 |
US |
34 | 1 |
Eczema, Thermohyperaesthesia, |
||||
DUPILUMAB, |
||||
| 25 | 26946096 |
US |
2 | |
Fatigue, Eczema, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 26 | 26946334 |
US |
2 | |
Eczema, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 27 | 26946338 |
US |
66 | 2 |
Pruritus, Urinary tract infection, Eczema, |
||||
DUPILUMAB, |
||||
| 28 | 26946782 |
US |
2 | |
Muscle discomfort, Eczema, Hypotension, Muscle tightness, Tinnitus, Fall, Scratch, Dizziness, Heart rate increased, Palpitations, Back pain, Bone pain, Fatigue, Headache, Arthralgia, Abdominal pain upper, Muscle spasms, Device leakage, |
||||
ABALOPARATIDE, ABALOPARATIDE, ESTRADIOL, FLUOROURACIL, MOMETASONE, ROSUVASTATIN, BRINZOLAMIDE/BRIMONIDINE TARTRATE, TIMOLOL MALEATE, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 29 | 26947796 |
US |
69 | |
Fatigue, Eczema, Myalgia, Urticaria, Drug ineffective, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 30 | 26948268 |
CA |
53 | 1 |
Cardiac murmur, Inappropriate schedule of product administration, Colitis ulcerative, Off label use, Gamma-glutamyltransferase increased, Haematocrit decreased, Lymphocyte count decreased, Neutrophil count increased, Monocyte count decreased, Uterine leiomyoma, Red cell distribution width increased, Hypersensitivity, Red blood cell count decreased, Pneumonia, Blood cholesterol increased, Platelet count increased, Haemoglobin decreased, Abdominal lymphadenopathy, Mean cell haemoglobin concentration decreased, C-reactive protein increased, Product use in unapproved indication, Systemic lupus erythematosus, Condition aggravated, Pyrexia, Frequent bowel movements, Drug ineffective, Confusional state, Mean platelet volume decreased, Migraine, Depression, Stress, Haematochezia, Bronchiectasis, Headache, Fatigue, Hypopnoea, Pain in extremity, Rhinitis, Deep vein thrombosis, Eczema, Parosmia, Steroid dependence, Abdominal discomfort, Gingival pain, Alcohol poisoning, Somnolence, Tinnitus, Pulmonary embolism, Catarrh, Accidental overdose, COVID-19, Vertigo, Weight decreased, Burns second degree, Dysgeusia, Rectal haemorrhage, Arthritis, Swollen tongue, Tubulointerstitial nephritis, Palpitations, Cerebrovascular accident, Rash, Nightmare, Pain, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, WARFARIN, WARFARIN, PREDNISONE, PREDNISONE, PREDNISONE, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, ROSUVASTATIN, ROSUVASTATIN, EPINEPHRINE, ADRENALINUM, CANDESARTAN CILEXETIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, VEDOLIZUMAB, VEDOLIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OXYCODONE, OXYCODONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ERGOCALCIFEROL, MESALAMINE, CALCIUM CARBONATE, ANTACID, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, FESOTERODINE FUMARATE, |
||||
| 31 | 26934080 |
US |
28 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 32 | 26934300 |
US |
60 | 2 |
Eczema, Temperature intolerance, |
||||
DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DULAGLUTIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 33 | 26934308 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 34 | 26934605 |
US |
23 | 2 |
Eczema, Pruritus, Rash, Product preparation error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 35 | 26934608 |
US |
2 | |
Eczema, Arthralgia, Skin discolouration, Skin swelling, |
||||
DUPILUMAB, |
||||
| 36 | 26934693 |
EU |
64 | 2 |
Gastrointestinal stromal tumour, Rash, Hypercholesterolaemia, Cystitis, Arteriosclerosis, Pain, Hyperlipidaemia, High density lipoprotein decreased, Fungal oesophagitis, Osteoarthritis, Urinary tract infection, Ligament rupture, Malaise, Haemorrhoids, Dizziness, Urinary incontinence, Nausea, Chest discomfort, Obstructive sleep apnoea syndrome, Dysuria, Arthralgia, Renal artery stenosis, Diabetes mellitus, Oedema peripheral, Snoring, Dysphagia, White blood cells urine positive, Wheezing, Insomnia, Hyperhomocysteinaemia, Tenosynovitis, Stress, Dyspepsia, Muscle spasticity, Scoliosis, Anxiety, Chest pain, Hiatus hernia, Influenza, Hypertensive crisis, Cholelithiasis, Pyrexia, Dyspnoea, Epicondylitis, Headache, Polyp, Ill-defined disorder, Cough, Trigger finger, Scar, Back pain, Nasopharyngitis, Oropharyngeal pain, Bradycardia, Blood calcium decreased, Eczema, Asthma, Limb discomfort, Drug hypersensitivity, Diastolic dysfunction, Spinal osteoarthritis, Arteriosclerosis coronary artery, Peripheral swelling, Paraesthesia, Acne, Gastrooesophageal reflux disease, Chronic gastritis, Throat irritation, Supraventricular extrasystoles, Torticollis, Abdominal distension, Tricuspid valve incompetence, Urine odour abnormal, Pain in extremity, |
||||
VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, AMLODIPINE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, VALSARTAN, VALSARTAN ORAL, DICLOFENAC, DICLOFENAC SODIUM, CANDESARTAN, HYDROCHLOROTHIAZIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SCOPOLAMINE, RAMIPRIL, TORSEMIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, INDAPAMIDE, NITROGLYCERIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, PROPOFOL, PROPOFOL, PROPOFOL, PROPOFOL, PROPOFOL, PROPOFOL, INDAPAMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, INDAPAMIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, PANTOPRAZOLE, PANTOPRAZOLE, DIAZEPAM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, AMLODIPINE BESYLATE, CANDESARTAN, AMLODIPINE BESYLATE, |
||||
| 37 | 26934872 |
US |
47 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 38 | 26935584 |
US |
33 | 1 |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 39 | 26935590 |
US |
1 | |
Hordeolum, Eczema, |
||||
DUPILUMAB, |
||||
| 40 | 26936008 |
US |
12 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 41 | 26936355 |
US |
55 | 1 |
Eczema, Dry skin, |
||||
DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, EVOLOCUMAB, |
||||
| 42 | 26936371 |
US |
46 | 1 |
Eczema, |
||||
SPARSENTAN, |
||||
| 43 | 26936760 |
US |
3 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 44 | 26936775 |
US |
71 | 2 |
Eczema, Dry skin, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
| 45 | 26936785 |
CA |
71 | |
Tooth extraction, Haematochezia, Weight increased, Weight decreased, Eczema, Rash macular, Abdominal pain, Refusal of treatment by patient, Condition aggravated, Incorrect dose administered, Product dose omission in error, Inappropriate schedule of product administration, Product dose omission issue, Off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ERGOCALCIFEROL, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 46 | 26937112 |
US |
19 | 2 |
Eczema, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 47 | 26937908 |
US |
2 | |
Eczema, Rash, |
||||
DUPILUMAB, |
||||
| 48 | 26938037 |
US |
31 | 1 |
Eczema, Eosinophil count increased, Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 49 | 26938445 |
US |
47 | 2 |
Eczema, Pneumonitis, |
||||
NIVOLUMAB, CABOZANTINIB, CABOZANTINIB, |
||||
| 50 | 26939269 |
US |
59 | 2 |
Eczema, Cheilitis, Palpitations, Headache, Nausea, |
||||
ABALOPARATIDE, |
||||
| 51 | 26931177 |
US |
2 | |
Eczema, Blister, Skin fissures, |
||||
DUPILUMAB, |
||||
| 52 | 26931250 |
IR |
37 | 2 |
Eczema, Prescribed underdose, |
||||
NATALIZUMAB, NATALIZUMAB, |
||||
| 53 | 26931449 |
US |
8 | 2 |
Pruritus, Eczema, Product dose omission issue, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MUPIROCIN, MUPIROCIN CALCIUM, MUPIROCIN, MUPIROCIN CALCIUM, |
||||
| 54 | 26931451 |
US |
37 | 2 |
Staphylococcal infection, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 55 | 26931625 |
US |
50 | 2 |
Pruritus, Peripheral swelling, Skin exfoliation, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 56 | 26931628 |
US |
1 | |
Erythema, Dermatitis, Eczema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 57 | 26931765 |
US |
56 | 2 |
Eczema, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 58 | 26932150 |
US |
45 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 59 | 26932153 |
US |
37 | 1 |
Abdominal discomfort, Injection site pain, Eczema, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 60 | 26932162 |
US |
1 | |
Fungal infection, Eczema, Rash, |
||||
DUPILUMAB, AMLODIPINE, TERBINAFINE HYDROCHLORIDE, ANTIFUNGAL, MICONAZOLE NITRATE, CLOTRIMAZOLE, MICONAZOLE, UNDECYLENIC ACID, TOLNAFTATE 1%, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATENOLOL, ATORVASTATIN CALCIUM, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 61 | 26932194 |
US |
19 | 2 |
Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 62 | 26932197 |
US |
76 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 63 | 26932199 |
US |
74 | 1 |
Eczema, Pruritus, Skin lesion, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 64 | 26932263 |
US |
17 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 65 | 26932308 |
US |
16 | 2 |
Eczema, Pustule, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 66 | 26932401 |
US |
1 | |
Eczema, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 67 | 26932418 |
US |
29 | 1 |
Eczema, Rash, Skin irritation, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 68 | 26932719 |
US |
1 | |
Eczema, Pruritus, Dry skin, |
||||
DUPILUMAB, ERENUMAB-AOOE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TAMSULOSIN HYDROCHLORIDE, |
||||
| 69 | 26932800 |
US |
69 | 1 |
Eczema, Therapeutic response shortened, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 70 | 26933138 |
US |
57 | 2 |
Eczema, Hidradenitis, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 71 | 26933253 |
US |
23 | 2 |
Eczema, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 72 | 26933282 |
US |
81 | 2 |
Eczema, Dry skin, Skin fissures, Eye pruritus, |
||||
DUPILUMAB, |
||||
| 73 | 26933305 |
US |
65 | 1 |
Eczema, Skin exfoliation, Dry skin, Pruritus, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 74 | 26933413 |
US |
31 | 2 |
Injection site discomfort, Eczema, Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, ERGOCALCIFEROL, |
||||
| 75 | 26933456 |
US |
61 | 1 |
Eczema, Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 76 | 26933496 |
US |
2 | |
Eczema, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 77 | 26933516 |
US |
63 | 1 |
Visual impairment, Vitreous floaters, Photopsia, Dry eye, Photophobia, Asthma, Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 78 | 26933553 |
US |
8 | 2 |
Eczema, Dermatitis atopic, Dermatitis allergic, |
||||
DUPILUMAB, DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 79 | 26933572 |
US |
12 | 2 |
Eczema, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 80 | 26933607 |
US |
2 | |
Illness, Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 81 | 26933632 |
US |
2 | 2 |
Eczema, Eczema eyelids, Injection site pain, Therapeutic response decreased, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 82 | 26933689 |
US |
2 | |
Eczema, Erythema, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 83 | 26933716 |
US |
33 | 1 |
Eczema, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 84 | 26933771 |
US |
69 | 2 |
Eczema, Skin weeping, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 85 | 26933794 |
US |
75 | |
Arthralgia, Eczema, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 86 | 26933821 |
US |
45 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 87 | 26926639 |
US |
1 | 1 |
Eczema, Dermatitis atopic, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 88 | 26927055 |
US |
79 | 1 |
Eczema, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 89 | 26927119 |
US |
54 | 2 |
Wheezing, Dizziness, Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 90 | 26927165 |
CA |
2 | |
Hypomagnesaemia, Small intestinal obstruction, Flatulence, Acute kidney injury, Human chorionic gonadotropin increased, Gastrointestinal disorder, Small intestinal stenosis, Vitamin B12 deficiency, Iron deficiency anaemia, Eczema, Nephrolithiasis, Abdominal distension, |
||||
RISANKIZUMAB-RZAA, |
||||
| 91 | 26927510 |
US |
33 | 2 |
Eczema, Product dose omission issue, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 92 | 26928432 |
US |
47 | 2 |
Pruritus, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 93 | 26928469 |
US |
42 | 1 |
Pruritus, Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 94 | 26928636 |
US |
13 | 2 |
Eczema, Dermatitis atopic, Pruritus, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 95 | 26928671 |
US |
19 | 2 |
Eczema, |
||||
TRALOKINUMAB-LDRM, |
||||
| 96 | 26928761 |
US |
66 | 2 |
Eczema, |
||||
TRALOKINUMAB-LDRM, |
||||
| 97 | 26928823 |
US |
51 | 1 |
Eczema, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 98 | 26928980 |
US |
1 | |
Eczema, Skin exfoliation, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 99 | 26929249 |
US |
1 | 1 |
Viral infection, Eczema, |
||||
DUPILUMAB, |
||||
| 100 | 26929341 |
US |
23 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30